EBGLYSS 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
EBGLYSS 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA
Commercialized
Register Number
1231765001
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Dec 21, 2023
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Route: VÍA SUBCUTÁNEA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1231765001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
LEBRIKIZUMABActive
Quantity: 250 mg
Name: LEBRIKIZUMAB
ATC CLASSIFICATION (3)
D11A
D11AH
D11AH10